← Back to search

Roivant Sciences Ltd

ROIV · NASDAQ

Pharmaceutical Preparation Manufacturing

Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch "Vants" - nimble and focused biopharmaceutical and health technology companies

ESG Scores

Overall ESG
4.8
Environmental
4.1
Social
2.1
Governance
6.6

Gender Diversity

Female Directors0.25%
CEO GenderMale

Market Data

Price$34.92+0.22 (+0.63%)
Market Cap$25.22B
P/E Ratio—
EPS$—
52W High$42.50
52W Low$16.88
Beta1.20